Smithkline Beecham (cork) Ltd

Sb Pharmco Puerto Rico Inc.

Christopher Werner

Philip C Dell'Orco

Christopher S Brook

Paul G Spoors

Lee M Katrincic

Wei Chen

Choon K Oh

Ann Marie Louvet

David H Igo

Qunying Dai

Ann Marie Diederich

Li-Jen Ping

Pingyun Y Chen

Clifford S Labaw

Claire Hisler

Jun Wang

The present invention relates to carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.

Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment

The present invention relates to a salt of carvedilol and/or corresponding solvates thereof, compositions containing such carvedilol and/or corresponding solvates thereof, and/or methods of using the aforementioned compound(s) in the treatment of certain disease states in mammals, in particular man. The present invention further relates to carvedilol phosphate salts, and/or solvates thereof, which include a novel crystalline form of carvedilol dihydrogen phosphate (i.e., which is the dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.) and/or other corresponding solvates thereof, compositions containing these carvedilol phosphate salts and/or solvates, and methods of using the aforementioned salts and/or solvates to treat hypertension, congestive heart failure and angina, etc.

Carvedilol salts, corresponding compositions, methods of delivery and/or treatment

Growing community of inventors

King of Prussia, PA, United States of America

Christopher Werner